PLEIADES: Daratumumab combinations for multiple myeloma
Dr Ajai Chari talks to ecancer at the International Myeloma Workshop 2019 about the PLEIADES studies.
The studies look at daratumumab in combination with a variety of standard multiple
myeloma treatment regimens.
Dr Chari outlines some of the data from this trial, as well as any toxicities.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php